Almirall (LTS:0O9B) EV-to-Revenue : 1.88 (As of Dec. 15, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Almirall EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Almirall's enterprise value is €1,782.3 Mil. Almirall's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €947.5 Mil. Therefore, Almirall's EV-to-Revenue for today is 1.88.

The historical rank and industry rank for Almirall's EV-to-Revenue or its related term are showing as below:

LTS:0O9B' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.17 Med: 2.81 Max: 4.48
Current: 1.88

During the past 13 years, the highest EV-to-Revenue of Almirall was 4.48. The lowest was 1.17. And the median was 2.81.

LTS:0O9B's EV-to-Revenue is ranked better than
59.96% of 994 companies
in the Drug Manufacturers industry
Industry Median: 2.495 vs LTS:0O9B: 1.88

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-15), Almirall's stock price is €8.325. Almirall's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €4.49. Therefore, Almirall's PS Ratio for today is 1.86.

Almirall EV-to-Revenue Historical Data

The historical data trend for Almirall's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall EV-to-Revenue Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

1.72

2.82

2.68

2.08

1.99

Almirall Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-Revenue	Get a 7-Day Free Trial															2.98	1.99	1.94	2.25	1.97

Competitive Comparison of Almirall's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Almirall's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Almirall's EV-to-Revenue falls into.

Almirall EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Almirall's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1782.280	/	947.516
	=	1.88

Almirall's current Enterprise Value is €1,782.3 Mil.
Almirall's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €947.5 Mil.

Almirall (LTS:0O9B) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Almirall's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	8.325	/	4.485
	=	1.86

Almirall's share price for today is €8.325.
Almirall's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.49.

Almirall EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Almirall's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (LTS:0O9B) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall Headlines

No Headlines